BioSpace News Archive

Rising cases of needle stick injuries, the shift in demand towards ambulatory surgical centers and fusion pumps, and a greater number of surgical procedures performed are poised to benefit the IV equipment market.

In developed countries, discretionary research funding for cancer is on a rise. Increased investments towards development of better treatment against malignant mesothelioma is observed globally.

In the minimally invasive surgeries, small incisions are made on the body. A laparoscope is inserted through one of the incisions or openings to serve as a guide during the surgery. A laparoscope is a tube like instrument that has a lens and a light for viewing. Also, tiny surgical instruments are inserted through other openings in order to undertake the surgery.

In the wake of SARS-CoV-2, another virus has been exposed in the U.S. Just as COVID-19 is a disease with many presentations, so is racism. Systemic racism exists in our country.

Extherid Biosciences LLC, a US-based CRO focused on experimental therapeutics and infectious diseases research, is excited to announce a merger with UK-based laboratory Perfectus Biomed Limited.

PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the Company’s proprietary Versamune® T-cell activating technology, today announced a Phase 2 clinical trial to evaluate its lead immunotherapy product, PDS0101,

Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the 41st Annual Goldman Sachs Global Healthcare Conference on Thursday, June 11, 2020 at 9:40 a.m. ET (2:40 p.m. BST).

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the Goldman Sachs 41st Annual Global Healthcare Conference Webcast at 9:40 a.m. ET on Thursday, June 11, 2020.

Universal Display Corporation (Nasdaq: OLED), enabling energy-efficient displays and lighting with its UniversalPHOLED® technology and materials, will hold its 2020 Annual Meeting of Shareholders in a virtual-only format beginning at 2:00pm Eastern Time on Thursday, June 18, 2020.

McKesson Corporation (NYSE:MCK) today announced Tom Rodgers has been appointed executive vice president and chief strategy and business development officer effective June 5, 2020. In his new role, Rodgers will also become a member of the company’s Executive Operating Team.